Literature DB >> 35201844

Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition.

David Hicks1, Ruth M O'Regan2,3.   

Abstract

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.

Entities:  

Mesh:

Year:  2022        PMID: 35201844     DOI: 10.1200/JCO.21.02850

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  1 in total

1.  Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.

Authors:  Mengdi Chen; Weilin Chen; Deyue Liu; Weiguo Chen; Kunwei Shen; Jiayi Wu; Li Zhu
Journal:  Breast Cancer       Date:  2022-06-21       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.